Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 200-203

  Koontz, Bridget F ^a   Tsivian, Matvey ^a   Mouraviev, Vladimir ^a   Sun, Leon ^a   Vujaskovic, Zeljko ^a   Moul, Judd ^a   Lee, W Robert ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Gleason grade; Intermediate risk; Radiation planning

Indexed keywords

BRACHYTHERAPY; GLEASON GRADE; GLEASON SCORES; MULTI VARIATE ANALYSIS; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; RADIATION PLANNING; RADIOTHERAPY TREATMENT; RESEARCH DATABASE; RISK STRATIFICATION; SEMINAL VESICLE; UNIVARIATE; UNIVARIATE ANALYSIS;

ANTIGENS; DIAGNOSIS; FAULT TOLERANT COMPUTER SYSTEMS; MULTIVARIANT ANALYSIS; NATURAL LANGUAGE PROCESSING SYSTEMS; PATHOLOGY; RADIOTHERAPY;

DISEASES;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; DISEASE SEVERITY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RACE; RISK ASSESSMENT; SEMINAL VESICLE DISEASE; TARGET ORGAN; TREATMENT PLANNING;

AGED; ANALYSIS OF VARIANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ORGAN SIZE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK; SEMINAL VESICLES;

EID: 83955161791     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.023     Document Type: Article

References (24)

1. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
2. A.W. Partin, M.W. Kattan, and E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
3. R.G. Stock, and N.N. Stone The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy Semin Surg Oncol 13 1997 454 460
4. S.J. Frank, P.D. Grimm, and J.E. Sylvester Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the United States Brachytherapy 6 2007 2 8
5. J.I. Epstein, W.C. Allsbrook Jr., and M.B. Amin Update on the Gleason grading system for prostate cancer: Results of an international consensus conference of urologic pathologists Adv Anat Pathol 13 2006 57 59
6. M.J. Burdick, C.A. Reddy, and J. Ulchaker Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer Int J Radiat Oncol Biol Phys 73 2009 1439 1445
7. D.E. Kang, N.J. Fitzsimons, and J.C. Presti Jr. Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: Results from the SEARCH database Urology 70 2007 277 282
8. D.V. Makarov, B.J. Trock, and E.B. Humphreys Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005 Urology 69 2007 1095 1101
9. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 2006 715 717
10. S.J. Freedland, L.L. Banez, and L.L. Sun Obese men have higher-grade and larger tumors: An analysis of the duke prostate center database Prostate Cancer Prostatic Dis 12 2009 259 263
11. Henry AM, Al-Qaisieh B, Gould K, et al. Outcomes following iodine-125 monotherapy for localized prostate cancer: The results of leeds 10-year single-center brachytherapy experience. Int J Radiat Oncol Biol Phys;76:50-56.
12. Taira AV, Merrick GS, Galbreath RW, et al. Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys;76:349-354.
13. J.M. Cosset, T. Flam, and N. Thiounn Selecting patients for exclusive permanent implant prostate brachytherapy: The experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients Int J Radiat Oncol Biol Phys 71 2008 1042 1048
14. G.S. Merrick, K.E. Wallner, and W.M. Butler Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland J Urol 169 2003 1643 1652
15. J. Katcher, P.A. Kupelian, and C. Zippe Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone Int J Radiat Oncol Biol Phys 37 1997 871 876
16. M.W. Kattan, A.M. Stapleton, and T.M. Wheeler Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma Cancer 79 1997 528 537
17. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005 7012
18. Tilki D, Schlenker B, John M, et al. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution series. Urol Oncol. In press.
19. Moussa AS, Kattan MW, Berglund R, et al. A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling. BJU Int 105:352-358.
20. M. Tsivian, L. Sun, and V. Mouraviev Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy Urology 74 2009 1090 1093
21. H.G. Sim, D. Telesca, and S.H. Culp Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence J Urol 179 2008 1775 1779
22. M.A. Vira, J.E. Tomaszewski, and W.T. Hwang Impact of the percentage of positive biopsy cores on the further stratification of primary Grade 3 and Grade 4 Gleason score 7 tumors in radical prostatectomy patients Urology 66 2005 1015 1019
23. S.E. Litwiller, B. Djavan, and B.V. Klopukh Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: Changing trends over a 10-year period (1984-1994). Dallas Outcomes Research Group for Urological Disorders Urology 45 1995 813 822
24. L. Richstone, F.J. Bianco, and H.H. Shah Radical prostatectomy in men aged > or = 70 years: Effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram BJU Int 101 2008 541 546